AnalystsTessa Romero
Tessa Romero's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 18%
#872 out of 4866 analysts
Average Return
+11.82%
Win Rate
35%15 out of 43
Risk vs Reward
Poor
Good

Tessa Romero's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+347.52%$7.07$31.64
2024-10-02 -
2025-04-22
Strong Buy
Dyne Therapeutics IncDYN
+307.09%$10.58$43.07
2023-08-08 -
2024-08-08
Strong Buy
Biohaven LtdBHVN
+174.33%$14.65$40.19
2023-01-03 -
2024-01-03
Strong Buy
Edgewise Therapeutics IncEWTX
+132.39%$7.75$18.01
2023-06-29 -
2024-06-28
Strong Buy
Biohaven LtdBHVN
+97.54%$19.88$39.27
2023-08-15 -
2024-08-15
Strong Buy

Tessa Romero's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dyne Therapeutics IncDYN
5Hold$17.00+71.54%Maintains
a month ago
Biohaven LtdBHVN
6Strong Buy$68.00+221.51%Maintains
2 months ago
Upstream Bio IncUPB
1Strong Buy$38.00+274.38%Initiates Coverage On
6 months ago
Neumora Therapeutics IncNMRA
4Hold$15.00+2,027.66%Downgrades
6 months ago
Scholar Rock Holding CorpSRRK
4Strong Buy$31.00-2.02%Maintains
6 months ago
Cytokinetics IncCYTK
4Strong Buy$71.00+87.78%Maintains
8 months ago
Eyepoint Pharmaceuticals IncEYPT
3Strong Buy$29.00+345.81%Maintains
8 months ago
Edgewise Therapeutics IncEWTX
8Strong Buy$31.00+129.12%Maintains
8 months ago
Agios Pharmaceuticals IncAGIO
6Hold$46.00+64.29%Reinstates
10 months ago
Acadia Pharmaceuticals IncACAD
6Strong Buy$25.00N/AMaintains
a year ago
Lexeo Therapeutics IncLXEO
1Strong Buy$20.00N/AInitiates Coverage On
a year ago
Y Mabs Therapeutics IncYMAB
5Strong Sell$7.00N/AMaintains
2 years ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$55.00N/AMaintains
2 years ago
Seres Therapeutics IncMCRB
1Hold$140.00N/AInitiates Coverage On
2 years ago
Global Blood Therapeutics IncGBT
2Hold$36.00N/AMaintains
3 years ago
Orchard Therapeutics PLCORTX
1Strong Buy$150.00N/AAssumes
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.